Bronchial and pharyngeal mucosa

The bronchial and pharyngeal mucosa is the specialized mucous membrane lining the respiratory tract from the throat to the bronchi. It serves as a critical interface between the external environment and the body, providing a physical and immunological barrier through the production of mucus and the action of ciliated cells (StatPearls, 2023). This tissue is a primary site of inflammation in conditions such as asthma, chronic obstructive pulmonary disease (COPD), and pharyngitis, where it undergoes structural changes like goblet cell hyperplasia and basement membrane thickening (NIH, 2022). While many therapeutic agents, including inhaled corticosteroids and local anesthetics, are administered directly to these surfaces, the mucosa itself is an anatomical structure containing multiple distinct molecular targets rather than a single protein or receptor (PubMed, 2021). Consequently, it is classified as a tissue-level site of action rather than a specific molecular therapeutic target. The health of this mucosa is vital for respiratory function, as it facilitates the warming, humidification, and filtration of inhaled air.

Other names

Respiratory mucosaAirway mucosaPharyngeal mucous membraneBronchial mucous membraneMucous membrane of the respiratory tract

Drugs applied to these mucosal surfaces typically interact with specific molecular targets within the tissue, such as voltage-gated sodium channels for local anesthesia or glucocorticoid receptors to modulate inflammatory gene expression (PubChem, 2024; PubMed, 2021).